Cancer
Malignant Thyroid Gland Neoplasm
CI-CAN-00003251Explore in graph →
Top-level176 active trials10 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003251Explore in graph →
Clinical trials
790 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (65)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02731352 | Study of Apatinib in Patients With Differentiated Thyroid Cancer | completed | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT05191927 | A Nomogram Model to Predict Central Lymphnode Metastasis in Thyroid Papillary Carcinoma | completed | — | 1,200 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jan 14, 2022 |
| NCT02878044 | Shared Decision Making in Patients With Thyroid Nodules | completed | N/A | 21 | Mayo ClinicOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT02178345 | Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer | completed | — | 123 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 8, 2021 | clinicaltrials |
| NCT02764554 | Post-Marketing Surveillance of Lenvima in Korean Patients | completed | — | 132 | Eisai Korea Inc.INDUSTRY | 1 | Oct 7, 2021 | clinicaltrials |
| NCT05052359 | Aberrant Helix Pomatia Agglutinin Binding Glycan Expression in Follicular Thyroid Tumours | completed | — | 37 | National University Health System, SingaporeOTHER | 1 | Oct 1, 2021 | clinicaltrials |
| NCT05054634 | Psycho-oncological Intervention Through Counselling in Patients With Differentiated Thyroid Cancer in Treatment With Radioiodine(COUNTHY) | completed | — | 75 | QuironsaludOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT03392402 | Molecular Classifier for the Fine Needle-based Assessment of Malignancy Risk in Thyroid Nodules(ThyroPred-1) | completed | — | 599 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Sep 5, 2021 | clinicaltrials |
| NCT03787121 | Estimation of Economic Consequences Linked With Different Care Management Pathways of Differentiated Thyroid Cancers(ECO-THYR) | completed | — | 361 | University Hospital, ToulouseOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT01208051 | Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer | completed | Phase 1 / Phase 2 | 127 | National Cancer Institute (NCI)NIH | 2 | Jul 15, 2021 | clinicaltrials |
| NCT03174925 | Ultrasound Elastography in Imaging Patients With Thyroid Nodules | completed | N/A | 55 | Stanford UniversityOTHER | 1 | Jul 8, 2021 | clinicaltrials |
| NCT02862470 | Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients | completed | — | 22 | National Taiwan University HospitalOTHER | 0 | Jul 6, 2021 | clinicaltrials |
| NCT00124527 | Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer | completed | Phase 2 | 35 | Eisai Inc.INDUSTRY | 6 | Jun 16, 2021 | clinicaltrials |
| NCT03469310 | Minimizing Narcotic Analgesics After Endocrine Surgery | completed | Phase 4 | 126 | Minerva A Romero ArenasOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT04876287 | Salivary dysfuncTion After Radioiodine Treatment(START) | completed | — | 138 | French Nuclear Safety and Radiation Protection Authority (ASNR)OTHER_GOV | 1 | May 10, 2021 | clinicaltrials |
| NCT00704730 | Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer(EXAM) | completed | Phase 3 | 330 | ExelixisINDUSTRY | 24 | Apr 20, 2021 | clinicaltrials |
| NCT04601298 | The Risk Stratification of Papillary Thyroid Cancer With AUS/FLUS by FNA | completed | — | 290 | Shanghai 10th People's HospitalOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT03031639 | Khon Kaen University's Thyroidectomy Registry | completed | — | 98 | Khon Kaen UniversityOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT01270321 | Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer | completed | Phase 2 | 42 | Emory UniversityOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT03072160 | Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2021 | clinicaltrials |
| NCT00514046 | Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer | completed | Phase 1 / Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 22, 2020 | clinicaltrials |
| NCT02138214 | Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer | completed | Phase 2 | 117 | University of Wisconsin, MadisonOTHER | 1 | Dec 21, 2020 | clinicaltrials |
| NCT04594720 | Circulating Biomarkers to Identify Thyroid Cancer | completed | — | 100 | Chang Gung Memorial HospitalOTHER | 1 | Oct 20, 2020 | clinicaltrials |
| NCT00341094 | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident | completed | — | 23,143 | National Cancer Institute (NCI)NIH | 1 | Oct 9, 2020 | clinicaltrials |
| NCT01441154 | Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment | completed | — | 16 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Sep 28, 2020 | clinicaltrials |
| NCT01728623 | A Study of E7080 in Subjects With Advanced Thyroid Cancer | completed | Phase 2 | 51 | Eisai Co., Ltd.INDUSTRY | 1 | Aug 14, 2020 | clinicaltrials |
| NCT00668811 | Sutent Adjunctive Treatment of Differentiated Thyroid Cancer(IIT Sutent) | completed | Phase 2 | 23 | Medstar Health Research InstituteOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT04500925 | The Incidence of Postoperative Re-stratification for Recurrence in Well-differentiated Thyroid Cancer - A Single Tertiary Israeli Center Experience | completed | — | 301 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 0 | Aug 5, 2020 | clinicaltrials |
| NCT01788982 | Nintedanib(BIBF1120) in Thyroid Cancer | completed | Phase 2 | 100 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 31, 2020 | clinicaltrials |
| NCT03294005 | Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography | completed | — | 1,949 | China Medical University HospitalOTHER | 1 | Jul 21, 2020 | clinicaltrials |
| NCT02726503 | Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer(HOPE) | completed | Phase 2 | 39 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Jun 17, 2020 | clinicaltrials |
| NCT04425512 | Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy | completed | N/A | 333 | Kahramanmaras Sutcu Imam UniversityOTHER | 0 | Jun 11, 2020 | clinicaltrials |
| NCT02223052 | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies | completed | Phase 1 | 89 | CelgeneINDUSTRY | 1 | May 12, 2020 | clinicaltrials |
| NCT02911155 | Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists | completed | — | 229 | National Cancer Institute (NCI)NIH | 1 | May 5, 2020 | clinicaltrials |
| NCT00784303 | Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology | completed | Phase 2 | 117 | Eisai Inc.INDUSTRY | 6 | Apr 22, 2020 | clinicaltrials |
| NCT00342407 | The Incidence of Breast and Other Cancers Among Female Flight Attendants | completed | — | 6,093 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2020 | clinicaltrials |
| NCT03969108 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Mar 27, 2020 | clinicaltrials |
| NCT03211117 | Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer | completed | Phase 2 | 3 | Mayo ClinicOTHER | 1 | Mar 25, 2020 | clinicaltrials |
| NCT03246659 | Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC(GRAN-T-MTC) | completed | Phase 1 | 16 | Paola Anna ErbaOTHER | 5 | Mar 20, 2020 | clinicaltrials |
| NCT00339716 | Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Belarus Following the Chernobyl Accident | completed | — | 19,456 | National Cancer Institute (NCI)NIH | 1 | Mar 16, 2020 | clinicaltrials |
| NCT02658513 | Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer | completed | — | 35 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT00625846 | Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer | completed | Phase 2 | 152 | National Cancer Institute (NCI)NIH | 5 | Feb 26, 2020 | clinicaltrials |
| NCT04274829 | Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid | completed | — | 300 | University of CagliariOTHER | 1 | Feb 18, 2020 | clinicaltrials |
| NCT02614495 | Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma | completed | Phase 2 | 66 | Hutchison Medipharma LimitedINDUSTRY | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03159585 | To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors | completed | Phase 1 | 6 | Zhujiang HospitalOTHER | 1 | Jan 22, 2020 | clinicaltrials |
| NCT00341185 | Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing | completed | — | 2,997 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00480428 | Radiation Exposure and Thyroid Disease in Kazakhstan | completed | — | 117 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00880503 | Collection of Tissue Samples for Study of Multidrug Resistance | completed | — | 325 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT03307694 | Thyroid Ultrasound Elasticity (TrUE) Imaging | completed | — | 31 | Emory UniversityOTHER | 1 | Dec 3, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jan 20, 2022source: clinicaltrials